P3-093: Correlative analyses of plasma cytokine / angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of 1st-line vandetanib (VAN) and / or carboplatin plus paclitaxel (CP) for advanced non small cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2007-08, Vol.2 (8), p.S718-S718
Main Authors: Heymach, J.V., Hanrahan, E.O., Lin, H.Y., Du, D.Z., Yan, S, Kim, E.S., Lee, J.J., Ryan, A.J., Tran, H.T., Johnson, B.E.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1097/01.JTO.0000284069.35181.74